Literature DB >> 16911687

Does the pancreas move with respiration?

Deepak Kumar Bhasin1, Surinder Singh Rana, Sujeet Jahagirdar, Birinder Nagi.   

Abstract

BACKGROUND AND AIM: The pancreas is a retroperitoneal organ and has been classically considered to be immobile on respiration. Recent radiological studies assessing the mobility of the pancreas have challenged this traditional concept. The present study was conducted to assess the movement of pancreas with respiration using fluoroscopy, a simple and inexpensive method.
METHODS: Patients with chronic pancreatitis who had either pancreatic calcification evident on fluoroscopy or an indwelling pancreatic duct stent were studied. The movement of the pancreas was assessed under fluoroscopy by measuring the displacement of the stent or calcification in relationship to the spine in maximum inspiration followed by maximum expiration.
RESULTS: Twenty-two patients (mean age 35.45 + or - 11.29 years, 17 men) with chronic pancreatitis were included in the study. Ten patients had pancreatic calcification and 12 had an indwelling pancreatic duct stent (two in the dorsal duct, 10 in the ventral duct). In all patients, the pancreas moved downward in the craniocaudal direction on deep inspiration. Pancreatic excursion from maximum inspiration to maximum expiration ranged from 0.1 to 3.4 cm. In addition, a medial movement of the head of pancreas was also noted in most of the patients. On univariate analysis, no association was found between the range of movement and the age or sex of the patient, duration or etiology of disease, presence or absence of calcification, severity of ductal changes of chronic pancreatitis and the length or diameter of the pancreatic stent placed.
CONCLUSION: The pancreas moves craniocaudally with respiration and the head moves medially on inspiration.

Entities:  

Mesh:

Year:  2006        PMID: 16911687     DOI: 10.1111/j.1440-1746.2006.04324.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Potential dosimetric benefits of adaptive tumor tracking over the internal target volume concept for stereotactic body radiation therapy of pancreatic cancer.

Authors:  Konstantina Karava; Stefanie Ehrbar; Oliver Riesterer; Johannes Roesch; Stefan Glatz; Stephan Klöck; Matthias Guckenberger; Stephanie Tanadini-Lang
Journal:  Radiat Oncol       Date:  2017-11-09       Impact factor: 3.481

2.  Colonic hematoma after extracorporeal shock wave lithotripsy for pancreatic stones: a case report.

Authors:  Yu Liu; Lu Hao; Teng Wang; Zhao-Shen Li; Zheng-Lei Xu; Liang-Hao Hu
Journal:  BMC Gastroenterol       Date:  2019-12-04       Impact factor: 3.067

3.  Fiducial-based image-guided SBRT for pancreatic adenocarcinoma: Does inter-and intra-fraction treatment variation warrant adaptive therapy?

Authors:  Colin S Hill; Sarah Han-Oh; Zhi Cheng; Ken Kang-Hsin Wang; Jeffrey J Meyer; Joseph M Herman; Amol K Narang
Journal:  Radiat Oncol       Date:  2021-03-19       Impact factor: 3.481

4.  Using the Diaphragm as a Tracking Surrogate in CyberKnife Synchrony Treatment.

Authors:  Guo-Quan Li; Jing Yang; Yan Wang; Mengjun Qiu; Zeyu Ding; Sheng Zhang; Sheng-Li Yang; Zhenjun Peng
Journal:  Med Sci Monit       Date:  2021-08-11

5.  Large mesenteric hematoma after extracorporeal shock wave lithotripsy for pancreatic stones: A case report.

Authors:  Yu Liu; Lu Hao; Li-Sheng Wang; Teng Wang; Zhao-Shen Li; Liang-Hao Hu; Zheng-Lei Xu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.817

6.  Transarterial fiducial marker implantation for CyberKnife radiotherapy to treat pancreatic cancer: an experience with 14 cases.

Authors:  Akira Imaizumi; Takuji Araki; Hiroki Okada; Yu Sasaki; Takafumi Komiyama; Toshihiro Suzuki; Hiroshi Takahashi; Hiroshi Onishi
Journal:  Jpn J Radiol       Date:  2020-09-11       Impact factor: 2.374

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.